Analysis repertory for the study
| Drug class | Type |
|---|---|
| Amphetamines | Amphetamine |
| Methamphetamine | |
| MDMA | |
| PMA | |
| PMMA | |
| 2-Fluoroamphetamine (2-FA) | |
| 3-Fluoroamphetamine (3-FA) | |
| 4-Fluoroamphetamine (4-FA, PFA) | |
| 4-Methylamphetamine | |
| 4-Methylthioamphetamine | |
| 4-Fluoromethamphetamine | |
| 4-Methylmethamphetamine (4-MMA) | |
| Opiates/opioids | Morphine |
| Codeine | |
| Ethylmorphine | |
| Oxycodone | |
| Tramadol | |
| Tapentadol | |
| AH-7921 | |
| Carfentanyl | |
| Fentanyl | |
| Methadone | |
| Buprenorphine | |
| 6-MAM | |
| Benzodiazepines | Alprazolam |
| Bentazepam | |
| Diazepam | |
| Diclazepam | |
| Etizolam | |
| Flubromazepam | |
| Fluntirazepam | |
| Oxazepam | |
| Clonazepam | |
| N-desmethyldiazepam | |
| Nitrazepam | |
| Pyrazolam | |
| Cannabis and synthetic cannabinoids | THC |
| 5F-Apinaca | |
| 5F-PB-22 | |
| AM-2201 | |
| AM-2233 | |
| AM-694 | |
| HU-210 | |
| JWH-015 | |
| JWH-018 | |
| JWH-019 | |
| JWH-073 | |
| JWH-081 | |
| JWH-122 | |
| JWH-200 | |
| JWH-203 | |
| JWH-210 | |
| JWH-250 | |
| JWH-251 | |
| MAM 2201 | |
| PB-22 | |
| RCS-4 | |
| RCS-4-C4 | |
| RCS-8 | |
| STS-135 | |
| UR-144 | |
| UR-144 Deg. | |
| URB 754 | |
| WIN 55.212–2 | |
| XLR-11 Deg. | |
| XRL-11 | |
| Cathinones | Ethylcathinone |
| 2-metylmetkatinon (2-MMC) | |
| 3-methylmethcathinone (3-MMC) | |
| 4-methylmethcathinone (4-MEC) | |
| Methylone (bk-MDMA, 3,4-methylenedioxy-N-methylcathinone) | |
| Alfa-PVP | |
| bk-MDDMA (dimethylone) | |
| MDPV (methylenedioxypyrovalerone) | |
| Pentedron | |
| Phenethylamines | 2C-C |
| 2C-I | |
| 2C-T-2 | |
| 2C-E | |
| 2C-T-7 | |
| 2C-P | |
| 2C-B | |
| DOB | |
| DOI | |
| Bromo-DragonFLY | |
| 25C-NBOMe | |
| 25I-NBOMe | |
| Butylone (bk-MBDB) | |
| BDB (1,3-benzodioxolylbutanamine) | |
| N,N-dimethyl-MDA | |
| 2,5-DMA (dimethoxyamphetamine) | |
| Aminoindanes | 2-AI (2-aminoindan) |
| MDAI (5,6-Methylenedioxy-2-aminoindane) | |
| Tryptamines | Dimethyltryptamine (DMT) |
| 5-MeO-DMT | |
| alfa-methyltryptamine | |
| Piperidines/pyrrolidines | 2-DPMP (Desoxypipradrol) |
| Ethylphenidate | |
| 3,4-CTMP (2,4-Dichloromethylphenidate) | |
| Piperazine derivatives | pFPP (p-fluorophenylpiperazine 1-(4- fluorophenylpiperazine) |
| 1-benzylpiperazine (BZP) | |
| TFMPP | |
| mCPP (1-(3-chlorophenyl) piperazine) | |
| Arylalkylamines | 6-APB |
| 5-APB | |
| 5-IT | |
| 6-APDB | |
| Miscellaneous | Methoxetamine |
| Xylazine | |
| Desomorphine | |
| Phenmetrazine | |
| Metaoxedrine (phenylephrine) | |
| Harmin | |
| Salvinorin A | |
| Tapentadol | |
| Homoamphetamine (3-amino-1-phenylbutane) | |
| Methiopropamine (MPA) | |
| Ketamine | |
| LSD | |
| Zolpidem | |
| Zopiclone | |
| Cocaine |
APB, Aminopropylbenzofuran; Deg, Diethylene glycol; FLY, 3C-Bromo-Dragonfly; IT, 5-(2-Aminopropyl)indole; MAM, Monoacetylmorphine; MDDMA, Hydrochloride; MDMA, Methylenedioxymethamphetamine; PFA, para-fluoroamphetamine; PMA, para-Methoxyamphetamine; PMMA, para-Methoxy-N-methylamphetamine; RCS, Research chemicals; STS, (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide; TFMPP, Trifluoromethylphenylpiperazine;THC, Tetrahydrocannabinol; UR, TMCP-018, KM-X1, MN-001, YX-17; URB, (6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one); WIN, (R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone; XLR, 5″-fluoro-UR-144.